Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

NCT07133776 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus (EBV) Infection
PD-1 Inhibitor
Tenofovir
Chidamide
Lenalidomide

Interventions

DRUG: PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV Infectious Diseases.

Sponsor

The Affiliated Hospital of Xuzhou Medical University